Abstracts Archive - Page 2039 of 2425 - ACR Meeting Abstracts

Abstract Number: 184 • 2014 ACR/ARHP Annual Meeting
Ultrasound Versus X-Rays Versus Synovial Fluid Analysis for the Diagnosis of Calcium Pyrophosphate Dihydrate Deposition Disease: Is It CPPD?
Georgios Filippou¹, Antonella Adinolfi¹, Sauro Lorenzini², Ilaria Bertoldi¹, Valentina Di Sabatino¹, Valentina Picerno¹, Luca Sconfienza³, Mauro Galeazzi¹ and Bruno Frediani¹, ¹University of Siena, Siena, Italy, ²Clinical medicine and Immunological science, Rheumatology Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy, ³University of Milan, Milan, Italy
Background/Purpose: The diagnosis of calcium pyrophosphate crystal (CPP) deposition disease (CPPD) is mainly based on the synovial fluid analysis and Xrays. US has demonstrated high…
Abstract Number: 183 • 2014 ACR/ARHP Annual Meeting
Musculoskeletal Ultrasound Reveals Calcific Deposition Arthropathy in Seronegative Inflammatory Arthritis Patients
Sheila L. Arvikar¹, Janice Lin² and Minna J. Kohler³, ¹Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Boston, MA, ²Dermatology, Brigham and Women's Hospital, Boston, MA, ³Rheumatology, Allergy, and Immunology, Massachusetts General Hospital / Harvard Medical School, Boston, MA
Background/Purpose Rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) have vastly improved the diagnosis of rheumatoid arthritis (RA), but the diagnosis and management of seronegative…
Abstract Number: 182 • 2014 ACR/ARHP Annual Meeting
Effect of Urate-Lowering Therapy on Radiographic Changes in Gout Patients
Seulkee Lee¹, Inyoung Kim¹, Hyemin Jeong¹, Jiwon Hwang¹, Hyungjin Kim¹, Jaejoon Lee², Hoon-Suk Cha¹ and Eun-mi Koh², ¹Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, ²Division of Rheumatology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Background/Purpose The aim of this study was to investigate the radiographic changes in patients with gout in association with the control of serum uric acid…
Abstract Number: 181 • 2014 ACR/ARHP Annual Meeting
Adherence to Treatment Recommendations of Gout: A Patient Survey in China
Feng Sheng, Xuejun Zeng and Weigang Fang, Medicine, Peking Union Medical College Hospital, Beijing, China
Background/Purpose The prevalence of gout appeared to be increasing in China as its economy developed rapidly in the past three decades. Though efficacious and affordable…
Abstract Number: 179 • 2014 ACR/ARHP Annual Meeting
Effect of Allopurinol on All-Cause Mortality in Adults with Incident Gout: Propensity Score Matched Landmark Analysis
Chang-Fu Kuo^1,2, Matthew J. Grainge³, Christian Mallen⁴, Weiya Zhang¹ and Michael Doherty⁵, ¹Academic Rheumatology, School of Clinical Sciences, University of Nottingham, Nottingham, United Kingdom, ²Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taipei, Taiwan, ³Division of Epidemiology and Public Health, School of Community Health Sciences,, University of Nottingham, Nottingham, United Kingdom, ⁴Research Institute for Primary Care and Health Sciences, Keele University, Keele, United Kingdom, ⁵Division of Rheumatology, Orthopedics and Dermatology, University of Nottingham, Nottingham, United Kingdom
Background/Purpose Although current guidelines recommend allopurinol as a first-line urate-lowering treatment for gout patients, whether the balance of potential benefits and risks can translate to…
Abstract Number: 178 • 2014 ACR/ARHP Annual Meeting
The Effect of Initiating Pharmacologic Insulin on Serum Uric Acid Levels in Patients with Diabetes
Lindsey MacFarlane¹, Chih-Chin Liu² and Daniel H. Solomon³, ¹Medicine, Brigham and Women's Hospital, Boston, MA, ²Rheumatology & Immunology, Brigham & Women's Hospital, Boston, MA, ³Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA
Background/Purpose Substantial evidence links gout and hyperuricemia to diabetes. Previous studies report an association between increasing uric acid (UA) levels, insulin resistance, and type 2…
Abstract Number: 177 • 2014 ACR/ARHP Annual Meeting
Increase in Thyroid Stimulating Hormone (TSH) Levels in Patients with Gout Treated with Inhibitors of Xanthine-Oxido-Reductase
Fernando Perez-Ruiz^1,2, Ana M. Herrero-Beites^1,3, M. Angeles Aniel-Quiroga⁴ and Sandra P Chinchilla⁵, ¹BioCruces Health Research Institute, Baracaldo, Spain, ²Servicio de Reumatologia, Hospital Universitario Cruces, Baracaldo, Spain, ³Physical Medicine Division, Hospital de Gorliz, Gorliz, Spain, ⁴Biochemistry, Hospital Universitario Cruces, Baracaldo, Spain, ⁵Rheumatology, Hospital Universitario Cruces, Baracaldo, Spain
Background/Purpose: Increase in thyroid stimulating hormone (TSH) levels over upper normal limit has been reported in a small percentage of patients treated with febuxostat, but…
Abstract Number: 196 • 2014 ACR/ARHP Annual Meeting
Dependence on Walking Aids Is Associated with Pain and Mobility Limitation after Total Hip Arthroplasty
Jasvinder A. Singh¹ and David Lewallen², ¹University of Alabama and VA Medical Center, Birmingham, AL, ²Orthopedics, Mayo Clinic college of medicine, Rochester, MN
Background/Purpose: To assess the association of dependence on walking aids with pain and function outcomes after total hip arthroplasty (THA).Methods: We used the Mayo Clinic…
Abstract Number: 195 • 2014 ACR/ARHP Annual Meeting
Dependence on Walking Aids and Patient-Reported Outcomes after Total Knee Arthroplasty
Jasvinder A. Singh¹ and David Lewallen², ¹University of Alabama and VA Medical Center, Birmingham, AL, ²Orthopedics, Mayo Clinic college of medicine, Rochester, MN
Background/Purpose: To examine whether function and pain outcomes of patients undergoing primary total knee arthroplasty (TKA) are changing over time.Methods: The Mayo Clinic Total Joint…
Abstract Number: 194 • 2014 ACR/ARHP Annual Meeting
Differences in Total Knee Replacement Outcomes Based on Age
Leslie Harrold¹, David Ayers², Wenjun Li², Vincent Pellegrini³, John Grady-Benson⁴, Jeroan Allison⁵ and Patricia D. Franklin², ¹Department of Orthopedics and Medicine, University of Massachusetts Medical School, Worcester, MA, ²Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, ³Medical University of South Carolina, Charleston, SC, ⁴Connecticut Joint Replacement Institute, Hartford, CT, ⁵Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA
Background/Purpose The fastest growing segment of the population undergoing total knee replacements (TKR) are patients younger than 130 surgeons across 22 states in the US. …
Abstract Number: 193 • 2014 ACR/ARHP Annual Meeting
Pre-Operative Pain and Function: Profiles of Patients Selected for Total Knee Replacement Among Surgeons in the United States
Uyen Sa D.T. Nguyen¹, David C. Ayers¹, Wenjun Li¹, Leslie Harrold² and Patricia D. Franklin¹, ¹Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, ²Department of Orthopedics and Medicine, University of Massachusetts Medical School, Worcester, MA
Background/Purpose: When knee pain is severe and frequent, or mobility and daily activities become difficult, a total knee replacement (TKR) remains the most effective treatment…
Abstract Number: 192 • 2014 ACR/ARHP Annual Meeting
Title: Use of Non-Traditional Modalities for Pain Management after Knee or Hip Joint Replacement
Jasvinder A. Singh¹, Celeste Lemay², Jeroan Allison³ and Patricia D. Franklin⁴, ¹University of Alabama at Birmingham, Birmingham, AL, ²University of Massachusetts Medical School, Worchester, MA, ³Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, ⁴Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA
Background/Purpose: Pain management is a major focus of the post-arthroplasty rehabilitation. A variety of pain treatments are used, including narcotics and non-narcotic analgesics. To our…
Abstract Number: 180 • 2014 ACR/ARHP Annual Meeting
Analytical Comparison Between Point of Care Uric Acid Testing Meters
Jonathan Paraskos¹, Zsofia Berke², Jason Cook¹, Jeffrey N. Miner³, Martin Braddock¹, Adam Platt¹ and Glen Hughes¹, ¹AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, ²R&D, AstraZeneca, Mölndal, Sweden, ³Ardea Biosciences, Inc., San Diego, CA
Background/Purpose: Gout is a chronic, painful, debilitating form of arthritis resulting from elevated levels of serum uric acid (SUA), termed hyperuricemia. Hyperuricemia is caused by…
Abstract Number: 171 • 2014 ACR/ARHP Annual Meeting
High-Protein Diet (Atkins Diet) and Uric Acid Response
Na Lu¹, Iris Shai², Yuqing Zhang¹, Gary Curhan³ and Hyon K. Choi⁴, ¹Boston University School of Medicine, Boston, MA, ²Harvard School of Public Health, Boston, MA, ³German Research Center for Environmental Health, Harvard Medical School, Boston, MA, ⁴Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose The conventional low-purine dietary approach to gout offers limited efficacy, palatability, and sustainability, and promotes increased consumption of refined carbohydrates and saturated fat that…
Abstract Number: 170 • 2014 ACR/ARHP Annual Meeting
Increased Risk of Skin Reactions with Gout Medications: An Analysis of VA Databases
Jasvinder A. Singh¹, Shuo Yang² and Jeff Foster³, ¹University of Alabama and VA Medical Center, Birmingham, AL, ²Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³The University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Dermatologic side effects to use of gout treatments are concerning to patients. The goal of the study was to assess the risk of occurrence…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].